228 related articles for article (PubMed ID: 15021830)
1. Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia.
Ahmed A; Huang L; Raftery AT; Ahmed AK; Fahmy H; El Nahas AM; Haylor JL
Transplantation; 2004 Mar; 77(5):686-92. PubMed ID: 15021830
[TBL] [Abstract][Full Text] [Related]
2. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW
J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308
[TBL] [Abstract][Full Text] [Related]
3. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
Islam M; Burke JF; McGowan TA; Zhu Y; Dunn SR; McCue P; Kanalas J; Sharma K
Kidney Int; 2001 Feb; 59(2):498-506. PubMed ID: 11168932
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow.
Vieira JM; Noronha IL; Malheiros DM; Burdmann EA
Transplantation; 1999 Dec; 68(11):1746-53. PubMed ID: 10609952
[TBL] [Abstract][Full Text] [Related]
5. Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy.
Shihab FS; Andoh TF; Tanner AM; Bennett WM
Am J Kidney Dis; 1997 Jul; 30(1):71-81. PubMed ID: 9214404
[TBL] [Abstract][Full Text] [Related]
6. Effect of FTY720 on chronic cyclosporine nephropathy in rats.
Kim JY; Lim SW; Li C; Kim JS; Ahn KO; Yang HJ; Choi BS; Kim YS; Kim J; Bang BK; Yang CW
Transplantation; 2005 Nov; 80(9):1323-30. PubMed ID: 16314802
[TBL] [Abstract][Full Text] [Related]
7. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
8. The effect of alpha-melanocyte-stimulating hormone on renal tubular cell apoptosis and tubulointerstitial fibrosis in cyclosporine A nephrotoxicity.
Lee SY; Jo SK; Cho WY; Kim HK; Won NH
Transplantation; 2004 Dec; 78(12):1756-64. PubMed ID: 15614148
[TBL] [Abstract][Full Text] [Related]
9. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy.
Li C; Yang CW; Park JH; Lim SW; Sun BK; Jung JY; Kim SB; Kim YS; Kim J; Bang BK
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F46-57. PubMed ID: 14519596
[TBL] [Abstract][Full Text] [Related]
10. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
Thomas SE; Andoh TF; Pichler RH; Shankland SJ; Couser WG; Bennett WM; Johnson RJ
Kidney Int; 1998 Apr; 53(4):897-908. PubMed ID: 9551396
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
Shihab FS; Bennett WM; Yi H; Choi SO; Andoh TF
Kidney Int; 2004 Apr; 65(4):1262-71. PubMed ID: 15086465
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity.
Feria I; Pichardo I; Juárez P; Ramírez V; González MA; Uribe N; García-Torres R; López-Casillas F; Gamba G; Bobadilla NA
Kidney Int; 2003 Jan; 63(1):43-52. PubMed ID: 12472767
[TBL] [Abstract][Full Text] [Related]
14. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
Shihab FS; Yi H; Bennett WM; Andoh TF
Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy.
Duymelinck C; Deng JT; Dauwe SE; De Broe ME; Verpooten GA
Kidney Int; 1998 Sep; 54(3):804-18. PubMed ID: 9734605
[TBL] [Abstract][Full Text] [Related]
17. Role of hypomagnesemia in chronic cyclosporine nephropathy.
Miura K; Nakatani T; Asai T; Yamanaka S; Tamada S; Tashiro K; Kim S; Okamura M; Iwao H
Transplantation; 2002 Feb; 73(3):340-7. PubMed ID: 11884928
[TBL] [Abstract][Full Text] [Related]
18. Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity.
Shihab FS; Bennett WM; Yi H; Andoh TF
Am J Transplant; 2002 Feb; 2(2):111-9. PubMed ID: 12099512
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
Sun QL; Li M; Rui HL; Chen YP
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):301-10. PubMed ID: 25500744
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy.
Shihab FS; Bennett WM; Tanner AM; Andoh TF
Kidney Int; 1997 Sep; 52(3):660-73. PubMed ID: 9291185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
